Back
Aquestive Therapeutics Vs. ACADIA Pharmaceuticals Industry Stock Comparison
Buy
71
AQST
Aquestive Therapeutics
Last Price:
5.53
Seasonality Move:
-3.4%
Sell
38
ACAD
ACADIA Pharmaceuticals
Last Price:
14.67
Seasonality Move:
14.68%
Buy
71
Aquestive Therapeutics (AQST)
is a Buy
Is Aquestive Therapeutics a Buy, Sell or Hold?
- The current Aquestive Therapeutics [AQST] share price is $5.50. The Score for AQST is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- AQST is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
- The current ACADIA Pharmaceuticals [ACAD] share price is $14.57. The Score for ACAD is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ACAD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AQST Stock Price Chart
What is Aquestive Therapeutics's stock price today?
-
The Aquestive Therapeutics share price today is $5.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AQST is experiencing slight selling pressure.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals's stock price today?
-
The ACADIA Pharmaceuticals share price today is $14.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing slight selling pressure.
AQST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 63.05 | Buy |
| Chaikin Money Flow: | -195057 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.74 - 5.36) | Buy |
| Bollinger Bands (100): | (2.97 - 4.97) | Buy |
ACAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 42.57 | Sell |
| Chaikin Money Flow: | -213833 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.5 - 15.22) | Sell |
| Bollinger Bands (100): | (14.77 - 17.37) | Sell |
AQST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.47 | Buy |
| 20-day SMA: | 5.11 | Buy |
| 50-day SMA: | 4.85 | Buy |
| 200-day SMA: | 3.75 | Buy |
| 8-day EMA: | 5.44 | Buy |
| 20-day EMA: | 5.2 | Buy |
| 50-day EMA: | 4.8 | Buy |
| 200-day EMA: | 3.74 | Buy |
ACAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.56 | Buy |
| 20-day SMA: | 14.73 | Sell |
| 50-day SMA: | 15.47 | Sell |
| 200-day SMA: | 18.12 | Sell |
| 8-day EMA: | 14.66 | Sell |
| 20-day EMA: | 14.84 | Sell |
| 50-day EMA: | 15.37 | Sell |
| 200-day EMA: | 17.76 | Sell |
Aquestive Therapeutics Earnings Growth & AQST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.12 per share.
ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and an increase next year of $0.29 per share.
Aquestive Therapeutics Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ACADIA Pharmaceuticals Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||